PPARA and Tay-Sachs disease: Since GFB is an agonist of peroxisome proliferator-activated receptor α (PPARα), we investigated its role in GFB-mediated neuroprotection and found that GFB remained unable to reduce TSD pathology and increase longevity in Tay-Sachs mice lacking PPARα.